JOSEPH MILLS to Platelet Aggregation Inhibitors
This is a "connection" page, showing publications JOSEPH MILLS has written about Platelet Aggregation Inhibitors.
Connection Strength
0.150
-
Balancing Long-Term Risks of Ischemic and Bleeding Complications After Percutaneous Coronary Intervention With Drug-Eluting Stents. Am J Cardiol. 2015 Sep 01; 116(5):686-93.
Score: 0.106
-
Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits. J Vasc Surg. 2023 04; 77(4):1107-1118.e2.
Score: 0.045